278 related articles for article (PubMed ID: 35348116)
21. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc
Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S
Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513
[TBL] [Abstract][Full Text] [Related]
22. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
23. Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells.
Metheny L; Eid S; Lingas K; Reese J; Meyerson H; Tong A; de Lima M; Huang AY
Hematol Med Oncol; 2016; 1(1):25-29. PubMed ID: 27882356
[TBL] [Abstract][Full Text] [Related]
24. [Study on hematopoiesis reconstitution by co-transplant of human bone marrow mesenchymal stem cells and umbilical cord blood CD34(+) cells at different ratios in NOD/SCID mice].
Ma LJ; Hu XX; Zhou H; Gao L; Xie LN; Qiu HY; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):684-8. PubMed ID: 19176064
[TBL] [Abstract][Full Text] [Related]
25. Engraftment capacity of umbilical cord blood cells processed by either whole blood preparation or filtration.
Eichler H; Kern S; Beck C; Zieger W; Klüter H
Stem Cells; 2003; 21(2):208-16. PubMed ID: 12634417
[TBL] [Abstract][Full Text] [Related]
26. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.
Lepus CM; Gibson TF; Gerber SA; Kawikova I; Szczepanik M; Hossain J; Ablamunits V; Kirkiles-Smith N; Herold KC; Donis RO; Bothwell AL; Pober JS; Harding MJ
Hum Immunol; 2009 Oct; 70(10):790-802. PubMed ID: 19524633
[TBL] [Abstract][Full Text] [Related]
27. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
28. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
[TBL] [Abstract][Full Text] [Related]
29. Correlation between chemokines released from umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice.
Noh YH; Yim YS; Kim DH; Lee MW; Kim DS; Kim HR; Lee SH; Chueh HW; Choi SJ; Oh WI; Yang YS; Jung HL; Yoo KH; Sung KW; Koo HH
Pediatr Hematol Oncol; 2011 Nov; 28(8):682-90. PubMed ID: 22023463
[TBL] [Abstract][Full Text] [Related]
30. No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.
van der Garde M; Brand A; Slot MC; de Graaf-Dijkstra A; Zwaginga JJ; van Hensbergen Y
Stem Cells Dev; 2015 Jun; 24(12):1448-56. PubMed ID: 25668618
[TBL] [Abstract][Full Text] [Related]
31. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice.
Hiwase SD; Dyson PG; To LB; Lewis ID
Stem Cells; 2009 Sep; 27(9):2293-300. PubMed ID: 19544531
[TBL] [Abstract][Full Text] [Related]
32. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
Kadekar D; Kale V; Limaye L
Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
[TBL] [Abstract][Full Text] [Related]
33. Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells.
Perna-Barrull D; Gomez-Muñoz L; Rodriguez-Fernandez S; Gieras A; Ampudia-Carrasco RM; Almenara-Fuentes L; Risueño RM; Querol S; Tolosa E; Vives-Pi M
Arch Immunol Ther Exp (Warsz); 2022 Dec; 71(1):1. PubMed ID: 36528821
[TBL] [Abstract][Full Text] [Related]
34. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
Zheng Y; Sun A; Han ZC
Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of efficacies of allogeneic hematopoietic stem cell transplantations between different routes of administration in mice].
Cai Y; Huang SL; Huang K; Chen HQ; Zhang XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):998-1004. PubMed ID: 17956678
[TBL] [Abstract][Full Text] [Related]
36. Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.
Lin H; De Stanchina E; Zhou XK; She Y; Hoang D; Cheung SW; Cassileth B; Cunningham-Rundles S
Exp Biol Med (Maywood); 2009 Mar; 234(3):342-53. PubMed ID: 19144872
[TBL] [Abstract][Full Text] [Related]
37. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation.
Kim DW; Chung YJ; Kim TG; Kim YL; Oh IH
Blood; 2004 Mar; 103(5):1941-8. PubMed ID: 14592834
[TBL] [Abstract][Full Text] [Related]
38. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow.
Yahata T; Ando K; Sato T; Miyatake H; Nakamura Y; Muguruma Y; Kato S; Hotta T
Blood; 2003 Apr; 101(8):2905-13. PubMed ID: 12411299
[TBL] [Abstract][Full Text] [Related]
39. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
